Transcription factors specificity protein and nuclear receptor 4A1 in pancreatic cancer
Open Access
- 14 October 2021
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 27 (38), 6387-6398
- https://doi.org/10.3748/wjg.v27.i38.6387
Abstract
Specificity protein (Sp) transcription factors (TFs) Sp1, Sp3 and Sp4, and the orphan nuclear receptor 4A1 (NR4A1) are highly expressed in pancreatic tumors and Sp1 is a negative prognostic factor for pancreatic cancer patient survival. Results of knockdown and overexpression of Sp1, Sp3 and Sp4 in pancreatic and other cancer lines show that these TFs are individually pro-oncogenic factors and loss of one Sp TF is not compensated by other members. NR4A1 is also a pro-oncogenic factor and both NR4A1 and Sp TFs exhibit similar functions in pancreatic cancer cells and regulate cell growth, survival, migration and invasion. There is also evidence that Sp TFs and NR4A1 regulate some of the same genes including survivin, epidermal growth factor receptor, PAX3-FOXO1, α5- and α6-integrins, β1-, β3- and β4-integrins; this is due to NR4A1 acting as a cofactor and mediating NR4A1/Sp1/4-regulated gene expression through GC-rich gene promoter sites. Several studies show that drugs targeting Sp downregulation or NR4A1 antagonists are highly effective inhibitors of Sp/NR4A1-regulated pathways and genes in pancreatic and other cancer cells, and the triterpenoid celastrol is a novel dual-acting agent that targets both Sp TFs and NR4A1.Keywords
This publication has 81 references indexed in Scilit:
- Low SP1 Expression Differentially Affects Intestinal-Type Compared with Diffuse-Type Gastric AdenocarcinomaPLOS ONE, 2013
- Predictive Value of Sp1/Sp3/FLIP Signature for Prostate Cancer RecurrencePLOS ONE, 2012
- Sp1 expression regulates lung tumor progressionOncogene, 2011
- Sp1 is upregulated in human glioma, promotes MMP‐2‐mediated cell invasion and predicts poor clinical outcomeInternational Journal of Cancer, 2011
- Inactivation of the Orphan Nuclear Receptor TR3/Nur77 Inhibits Pancreatic Cancer Cell and Tumor GrowthCancer Research, 2010
- Dual Role of Sp3 Transcription Factor as an Inducer of Apoptosis and a Marker of Tumour AggressivenessPLOS ONE, 2009
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- Sp1, a New Biomarker That Identifies a Subset of Aggressive Pancreatic Ductal AdenocarcinomaCancer Epidemiology, Biomarkers & Prevention, 2008
- Downregulation of transcription factor, Sp1, during cellular senescenceBiochemical and Biophysical Research Communications, 2007
- The NR4A Subgroup: Immediate Early Response Genes with Pleiotropic Physiological RolesNuclear Receptor Signaling, 2005